​

Neurocrine Biosciences Ownership | Who Owns Neurocrine Biosciences?

OverviewForecastRevenueFinancialsChartTranscripts

Neurocrine Biosciences Ownership Summary

Neurocrine Biosciences is owned by 101.01% institutional investors, 1.06% insiders. Blackrock is the largest institutional shareholder, holding 14.22% of NBIX shares. Dodge & Cox Stock I is the top mutual fund, with 3.94% of its assets in Neurocrine Biosciences shares.

NBIX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockNeurocrine Biosciences101.01%1.06%-2.07%
SectorHealthcare Stocks 50.47%12.28%37.25%
IndustryBiotech Stocks 49.08%12.05%38.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock14.19M14.22%$1.95B
Blackrock funding, inc. /de13.71M13.64%$2.31B
Vanguard group9.70M9.76%$1.38B
Jpmorgan chase6.40M6.37%$1.09B
Dodge & cox5.58M5.56%$941.22M
Vanguard capital management4.55M4.52%$766.05M
State street4.39M4.36%$739.13M
Aqr capital management3.82M3.80%$643.47M
Renaissance2.34M2.32%$393.68M
Geode capital management2.14M2.13%$359.61M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sarissa capital management lp116.53K11.04%$19.64M
Vestal point capital, lp1.88M7.40%$316.85M
Healthinvest partners ab72.90K3.31%$12.29M
Pfm health sciences, lp213.41K3.09%$35.97M
Avidity partners management lp220.40K2.95%$30.08M
Iron triangle partners lp131.39K2.62%$18.44M
Science & technology partners79.72K2.26%$13.44M
Birchview capital, lp27.19K2.14%$4.58M
Braidwell lp336.17K2.10%$56.66M
Seizert capital partners277.34K1.93%$46.74M

Top Buyers

HolderShares% AssetsChange
Sixth street partners management company974.28K0.02%974.28K
Norges bank973.88K0.02%973.88K
Jpmorgan chase6.40M0.06%956.61K
Invesco1.08M0.01%721.31K
Vestal point capital, lp1.88M7.40%630.00K

Top Sellers

HolderShares% AssetsChange
Wellington management group llp34.64K0.00%-1.35M
Millennium management11.59K0.00%-1.24M
Aqr capital management3.82M0.22%-1.12M
Two sigma investments, lp2.08M0.25%-984.31K
Dsm capital partners---932.60K

New Positions

HolderShares% AssetsChangeValue
Sixth street partners management company974.28K0.02%974.28K$164.20M
Norges bank973.88K0.02%973.88K$164.13M
Australiansuper pty348.99K0.25%348.99K$58.82M
Axa investment managers323.90K0.12%323.90K$45.47M
Nearwater capital markets155.00K0.45%155.00K$26.12M

Sold Out

HolderChange
Wealthtrak capital management-1.00
Wealth watch advisors-1.00
New millennium group-1.00
Nemes rush group-1.00
Turning point benefit group-2.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20267859.48%101,517,6861.53%1011.02%45817.14%2243.70%
Mar 31, 2026694-6.72%98,421,444-0.74%980.99%373-9.69%211-3.65%
Dec 31, 2025286-56.60%23,096,413-76.21%230.24%161-53.47%78-63.72%
Sep 30, 2025313-46.40%27,003,435-70.64%270.32%165-45.54%95-55.40%
Jun 30, 20255880.17%97,956,5484.05%981.11%30220.32%215-15.02%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Dodge & Cox Stock I3.96M3.94%-
iShares Core S&P Mid-Cap ETF3.45M3.40%106.00
Vanguard US Total Market Shares ETF3.20M3.21%2.53K
Vanguard Total Stock Mkt Idx Inv3.19M3.18%-1.38K
Vanguard Morn Total Stk Mkt Idx Investor3.19M3.18%-1.38K
Vanguard Small Cap Index2.31M2.29%-3.30K
BB Biotech AG Ord1.76M1.75%-60.00K
JPMorgan Growth Advantage A1.36M1.35%-62.59K
Vanguard Morn Small Cap Growth Index Inv1.33M1.32%32.38K
Vanguard Small Cap Growth Index Inv1.33M1.32%32.38K

Recent Insider Transactions

DateNameRoleActivityValue
Jul 28, 2026Norwalk Leslie V-Sell$227.51K
Jul 10, 2026Delaet Ingrid Chief Regulatory OfficerSell$790.51K
Jul 09, 2026Lippoldt Darin Chief Legal OfficerSell$1.80M
Jul 07, 2026Delaet Ingrid Chief Regulatory OfficerSell$607.31K
Jul 08, 2026Delaet Ingrid Chief Regulatory OfficerSell$488.67K

Insider Transactions Trends

DateBuySell
2026 Q3-6
2026 Q2-21
2026 Q1-2
2025 Q4-8
2025 Q3-4

NBIX Ownership FAQ

Who Owns Neurocrine Biosciences?

Neurocrine Biosciences shareholders are primarily institutional investors at 101.01%, followed by 1.06% insiders and -2.07% retail investors. The average institutional ownership in Neurocrine Biosciences's industry, Biotech Stocks , is 49.08%, which Neurocrine Biosciences exceeds.

Who owns the most shares of Neurocrine Biosciences?

Neurocrine Biosciences’s largest shareholders are Blackrock (14.19M shares, 14.22%), Blackrock funding, inc. /de (13.71M shares, 13.64%), and Vanguard group (9.7M shares, 9.76%). Together, they hold 37.62% of Neurocrine Biosciences’s total shares outstanding.

Does Blackrock own Neurocrine Biosciences?

Yes, BlackRock owns 14.22% of Neurocrine Biosciences, totaling 14.19M shares as of Jun 2024. This represents 0.04% of BlackRock's total assets, with a market value of 1.95B$. In the last quarter, BlackRock increased its holdings by 429.74K shares, a 3.12% change.

Who is Neurocrine Biosciences’s biggest shareholder by percentage of total assets invested?

Sarissa capital management lp is Neurocrine Biosciences’s biggest shareholder by percentage of total assets invested, with 11.04% of its assets in 116.53K Neurocrine Biosciences shares, valued at 19.64M$.

Who is the top mutual fund holder of Neurocrine Biosciences shares?

Dodge & Cox Stock I is the top mutual fund holder of Neurocrine Biosciences shares, with 3.94% of its total shares outstanding invested in 3.96M Neurocrine Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools